谷歌浏览器插件
订阅小程序
在清言上使用

First-Mind: Primary Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Blood(2021)

引用 2|浏览21
暂无评分
摘要
Introduction
更多
查看译文
关键词
tafasitamab,first-mind,open-label,r-chop,b-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要